Omeros (OMER) Net Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | -1,000.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,000.58% |
| Dec 31, 2025 | 286.64% |
| Sep 30, 2025 | 185.48% |
| Jun 30, 2025 | -922.84% |
| Mar 31, 2025 | 116.33% |
| Dec 31, 2024 | 107.98% |
| Sep 30, 2024 | -102.49% |
| Jun 30, 2024 | -89.58% |
| Mar 31, 2024 | 26.55% |
| Dec 31, 2023 | 82.50% |
| Sep 30, 2023 | -81.71% |
| Jun 30, 2023 | -46.38% |
| Mar 31, 2023 | 92.18% |
| Dec 31, 2022 | -244.04% |
| Sep 30, 2022 | 2,585.28% |
| Jun 30, 2022 | 40.80% |
| Mar 31, 2022 | -6,135.23% |
| Dec 31, 2021 | 983.23% |
| Sep 30, 2021 | -127.66% |
| Jun 30, 2021 | 171.28% |
| Mar 31, 2021 | -136.51% |
| Dec 31, 2020 | -83.04% |
| Sep 30, 2020 | 292.02% |
| Jun 30, 2020 | -7,479.41% |
| Mar 31, 2020 | 323.24% |
| Dec 31, 2019 | -287.93% |
| Sep 30, 2019 | 5,178.13% |
| Jun 30, 2019 | -104.01% |
| Mar 31, 2019 | 18.05% |
| Dec 31, 2018 | 29.81% |
| Sep 30, 2018 | 95.93% |
| Jun 30, 2018 | -19.49% |
| Mar 31, 2018 | -134.08% |
| Dec 31, 2017 | 129.33% |
| Sep 30, 2017 | -141.35% |
| Jun 30, 2017 | -41.73% |
| Mar 31, 2017 | -143.41% |
| Dec 31, 2016 | -1,156.68% |
| Sep 30, 2016 | 391.22% |
| Jun 30, 2016 | 222.41% |
| Mar 31, 2016 | -135.60% |
| Dec 31, 2015 | 292.93% |
| Sep 30, 2015 | -150.32% |
| Jun 30, 2015 | 15.94% |
| Mar 31, 2015 | 233.05% |
| Dec 31, 2014 | -269.23% |
| Sep 30, 2014 | -38.34% |
| Jun 30, 2014 | 122.07% |
| Mar 31, 2014 | -241.84% |
| Dec 31, 2013 | -49.13% |
| Sep 30, 2013 | 90.88% |
| Jun 30, 2013 | 104.56% |
| Mar 31, 2013 | -101.87% |
| Dec 31, 2012 | 152.10% |
| Sep 30, 2012 | -951.58% |
| Jun 30, 2012 | -4,105.88% |
| Mar 31, 2012 | 1,890.20% |
| Dec 31, 2011 | -283.20% |
| Sep 30, 2011 | 1,046.75% |